Hepatocellular Carcinoma: Diagnosis, staging, and treatment strategy

被引:24
作者
Vilana, R. [1 ,3 ]
Forner, A. [2 ,3 ]
Garcia, A. [1 ,3 ]
Ayuso, C. [1 ,3 ]
Bru, C. [1 ,3 ]
机构
[1] Hosp Clin Barcelona, CDIC, Serv Radiodiag, Barcelona, Spain
[2] Hosp Clin Barcelona, Inst Enfermedades Digestiv & Metab IMDM, Serv Hepatol, Barcelona, Spain
[3] Univ Barcelona, Hosp Clin, IDIBAPS, CIBERehd,Unidad Oncol Hepaat BCLC Grp, Barcelona, Spain
来源
RADIOLOGIA | 2010年 / 52卷 / 05期
关键词
Hepatocellular carcinoma; Ultrasonography; Contrast-enhanced ultrasonography; Computed tomography; Magnetic resonance imaging; Screening; Diagnostic imaging; Biopsy; Tumor treatment;
D O I
10.1016/j.rx.2010.05.003
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 [临床医学]; 100207 [影像医学与核医学]; 1009 [特种医学];
摘要
Hepatocellular carcinoma is a tumor with a high incidence and high mortality. These data justify screening programs to enable curative treatments to improve survival rates. Screening the population at risk (mainly patients with cirrhosis of the liver) should include ultrasonographic examination twice yearly. Given the vascular characteristics of hepatocellular carcinoma, it can be detected using dynamic techniques (contrast-enhanced ultrasonography, CT, and MRI). In cases in which the enhancement pattern is not characteristic, these techniques should be complemented with lesion biopsy. Once hepatocellular carcinoma is diagnosed, the tumor is staged, and together with the clinical condition of the patient, the stage will determine the most appropriate treatment strategy in each case. (C) 2009 SERAM. Published by Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:385 / 398
页数:14
相关论文
共 70 条
[1]
Arguedas MR, 2003, AM J GASTROENTEROL, V98, P679, DOI [10.1016/S0002-9270(02)06049-5, 10.1111/j.1572-0241.2003.07327.x]
[2]
NATURAL-HISTORY OF SMALL UNTREATED HEPATOCELLULAR-CARCINOMA IN CIRRHOSIS - A MULTIVARIATE-ANALYSIS OF PROGNOSTIC FACTORS OF TUMOR-GROWTH RATE AND PATIENT SURVIVAL [J].
BARBARA, L ;
BENZI, G ;
GAIANI, S ;
FUSCONI, F ;
ZIRONI, G ;
SIRINGO, S ;
RIGAMONTI, A ;
BARBARA, C ;
GRIGIONI, W ;
MAZZIOTTI, A ;
BOLONDI, L .
HEPATOLOGY, 1992, 16 (01) :132-137
[3]
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis [J].
Bolondi, L ;
Sofia, S ;
Siringo, S ;
Gaiani, S ;
Casali, A ;
Zironi, G ;
Piscaglia, F ;
Gramantieri, L ;
Zanetti, M ;
Sherman, M .
GUT, 2001, 48 (02) :251-259
[4]
Screening for hepatocellular carcinoma in cirrhosis [J].
Bolondi, L .
JOURNAL OF HEPATOLOGY, 2003, 39 (06) :1076-1084
[5]
Primary liver cancer:: Worldwide incidence and trends [J].
Bosch, FX ;
Ribes, J ;
Díaz, M ;
Cléries, R .
GASTROENTEROLOGY, 2004, 127 (05) :S5-S16
[6]
Current concepts - Computed tomography - An increasing source of radiation exposure [J].
Brenner, David J. ;
Hall, Eric J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (22) :2277-2284
[7]
DIAGNOSTIC-ACCURACY OF FINE-NEEDLE ASPIRATION BIOPSY IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA [J].
BRU, C ;
MAROTO, A ;
BRUIX, J ;
FAUS, R ;
BIANCHI, L ;
CALVET, X ;
AYUSO, C ;
VILANA, R ;
GILABERT, R ;
RODES, J .
DIGESTIVE DISEASES AND SCIENCES, 1989, 34 (11) :1765-1769
[8]
Management of hepatoceullular carcinoma [J].
Bruix, J ;
Sherman, M .
HEPATOLOGY, 2005, 42 (05) :1208-1236
[9]
Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference [J].
Bruix, J ;
Sherman, M ;
Llovet, JM ;
Beaugrand, M ;
Lencioni, R ;
Burroughs, AK ;
Christensen, E ;
Pagliaro, L ;
Colombo, M ;
Rodés, J .
JOURNAL OF HEPATOLOGY, 2001, 35 (03) :421-430
[10]
Sustained virological response to interferon-α is associated with improved outcome in HCV-related cirrhosis:: A retrospective study [J].
Bruno, Savino ;
Stroffolini, Tommaso ;
Colombo, Massimo ;
Bollani, Simona ;
Benvegnu, Luisa ;
Mazzella, Giuseppe ;
Ascione, Antonio ;
Santantonio, Teresa ;
Piccinino, Felice ;
Andreone, Pietro ;
Mangia, Alessandra ;
Gaeta, Giovanni B. ;
Persico, Marcello ;
Fagiuoli, Stefano ;
Almasio, Piero L. .
HEPATOLOGY, 2007, 45 (03) :579-587